Publications by authors named "Neus Gimenez"

Claim this Profile
P
Performance of SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Tests for Omicron and Other Variants of Concern.
Dàlia Raïch-Regué, Jordana Muñoz-Basagoiti, Daniel Perez-Zsolt, Marc Noguera-Julian, Edwards Pradenas

Front Microbiol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systems biology drug screening identifies statins as enhancers of current therapies in chronic lymphocytic leukemia.
Neus Gimenez, Rupal Tripathi, Ariadna Giró, Laia Rosich, Mònica López-Guerra

Sci Rep· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells.
Mónica López-Guerra, Sílvia Xargay-Torrent, Patricia Fuentes, Jocabed Roldán, Blanca González-Farré

Oncogene· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting IRAK4 disrupts inflammatory pathways and delays tumor development in chronic lymphocytic leukemia.
Neus Giménez, Ralph Schulz, Morihiro Higashi, Marta Aymerich, Neus Villamor

Leukemia· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia.
Neus Giménez, Alejandra Martínez-Trillos, Arnau Montraveta, Mónica Lopez-Guerra, Laia Rosich

Haematologica· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA.
Simon Heine, Markus Kleih, Neus Giménez, Kathrin Böpple, German Ott

J Hematol Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New drug discovery approaches targeting recurrent mutations in chronic lymphocytic leukemia.
Rupal Tripathi, Eriong Lee-Verges, Morihiro Higashi, Neus Gimenez, Laia Rosich

Expert Opin Drug Discov· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis